Inventor · disambiguated record
Cecile Pegurier
Also filed as: PEGURIER CECILE · PEGURIER CÉCILE
6 granted patents·3 pending applications·0 citations·filing 2007–2023
66Inventor score
Top patents by PatentIndex Score
9 records- 0173US2023348384A1Aza (Indole)-, Benzothiophene-, And Benzofuran-3-SulfonamidesUCB PHARMA GMBH·Filed 2023·Application pending·0 cites
- 0267US12071404B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2021·Granted Aug 27, 2024·0 cites·58 claims
- 0367US11820746B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2022·Granted Nov 21, 2023·0 cites·34 claims
- 0456US11345662B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2017·Granted May 31, 2022·0 cites·47 claims
- 0549US11976056B2Substituted alkoxypyridinyl indolsulfonamidesUCB PHARMA GMBH·Filed 2019·Granted May 7, 2024·0 cites·20 claims
- 0646US2010298289A1Heterobicyclic compounds as histamine h4-receptor antagonistsUCB PHARMA SA·Filed 2008·Application pending·0 cites
- 0745US2010035863A12 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical CompositionsUCB PHARMA SA·Filed 2007·Application pending·0 cites
- 0842US11939319B2Pyridinyl and pyrazinyl-(asa)indolsulfonamidesUCB PHARMA GMBH·Filed 2019·Granted Mar 26, 2024·0 cites·34 claims
- 0941US12358875B2N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosisUCB PHARMA GMBH·Filed 2020·Granted Jul 15, 2025·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Cecile Pegurier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →